Detalhe da pesquisa
1.
Systemic inflammatory biomarkers as predictive and prognostic factors in men with metastatic castration-refractory prostate cancer treated with docetaxel therapy: a comprehensive analysis in a German real-world cohort.
J Cancer Res Clin Oncol;
149(7): 3371-3381, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35939112
2.
Changes in neutrophile-to-lymphocyte ratio as predictive and prognostic biomarker in metastatic prostate cancer treated with taxane-based chemotherapy.
Discov Oncol;
13(1): 140, 2022 Dec 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36522513
3.
Baseline Modified Glasgow Prognostic Score (mGPS) Predicts Radiologic Response and Overall Survival in Metastatic Hormone-sensitive Prostate Cancer Treated With Docetaxel Chemotherapy.
Anticancer Res;
42(4): 1911-1918, 2022 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35347010